Literature DB >> 25937598

Nesfatin-1 antagonized rotenone-induced neurotoxicity in MES23.5 dopaminergic cells.

Zhen Tan1, Huamin Xu1, Xiaoli Shen1, Hong Jiang2.   

Abstract

Nesfatin-1 is a recently identified brain-gut peptide involved in feeding and energy homeostasis. Recently, it has been proved that nesfatin-1 could exert its neuroprotective effect against subarachnoid hemorrhage-induced injury via its anti-apoptotic and anti-inflammatory properties. However, whether it has neuroprotective effect on dopamine neurons is largely unknown. In the present study, we investigated the neuroprotective effect of nesfatin-1 on rotenone-treated MES23.5 dopaminergic cells and illustrated the underlying mechanisms. Our results showed that nesfatin-1 pretreatment could significantly attenuate rotenone-induced cell loss. Further studies showed that the neuroprotective effect of nesfatin-1 against rotenone was mediated by reversing rotenone-induced mitochondrial dysfunction. Nesfatin-1 could rescue rotenone-induced mitochondrial transmembrane potential collapse and restore the function of mitochondrial respiratory chain complex I. In addition, rotenone-induced release of cytochrome C from mitochondria, ROS production and the subsequent caspase-3 activation were also attenuated by nesfatin-1 pretreatment. Our data suggested that nesfatin-1 exerted its neuroprotective effect on dopaminergic cells against rotenone by ameliorating mitochondrial dysfunction and its anti-apoptotic property. This suggested that nesfatin-1 had the potential to be considered as an aid for prevention of Parkinson's disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Dopamine neuron; Nesfatin-1; Parkinson's disease; Rotenone

Mesh:

Substances:

Year:  2015        PMID: 25937598     DOI: 10.1016/j.peptides.2015.04.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  Protective effects of Nesfatin-1 peptide on cerebral ischemia reperfusion injury via inhibition of neuronal cell death and enhancement of antioxidant defenses.

Authors:  Sohaila Erfani; Ali Moghimi; Nahid Aboutaleb; Mehdi Khaksari
Journal:  Metab Brain Dis       Date:  2018-09-30       Impact factor: 3.584

Review 2.  Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.

Authors:  Dong Dong; Junxia Xie; Jun Wang
Journal:  Neurosci Bull       Date:  2019-07-08       Impact factor: 5.203

3.  The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson's disease.

Authors:  Gülser Karadaban Emir; Yasemin Ünal; Nigar Yılmaz; Kürsad Tosun; Gülnihal Kutlu
Journal:  Neurol Sci       Date:  2019-07-06       Impact factor: 3.307

Review 4.  "Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin.

Authors:  Xi Chen; Jing Dong; Qian Jiao; Xixun Du; Mingxia Bi; Hong Jiang
Journal:  Cell Mol Life Sci       Date:  2022-03-03       Impact factor: 9.261

Review 5.  Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

6.  Nesfatin-1 protects dopaminergic neurons against MPP+/MPTP-induced neurotoxicity through the C-Raf-ERK1/2-dependent anti-apoptotic pathway.

Authors:  Xiao-Li Shen; Ning Song; Xi-Xun Du; Yong Li; Jun-Xia Xie; Hong Jiang
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 7.  Potential Crosstalk Between Parkinson's Disease and Energy Metabolism.

Authors:  Meiqiu Liu; Qian Jiao; Xixun Du; Mingxia Bi; Xi Chen; Hong Jiang
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

8.  Nesfatin-1 alleviates high glucose/high lipid-induced injury of trophoblast cells during gestational diabetes mellitus.

Authors:  Huanling He; Yingyu Liu; Minghe Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.